[SRNE] YoY Quarter Result on 31-Mar-2014 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
14-May-2014
Financial Year
2014
Quarter
31-Mar-2014 [#Q1]
Profit Trend
QoQ- 10.65%
YoY- -300.20%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 4,874 988 977 976 134 110 235 65.67%
PBT -25,499 -20,027 -10,616 -10,093 -2,522 -906 -684,443 -42.17%
Tax -1,696 -1,637 -178 4 2 3 1,644 -
NP -23,064 -18,390 -10,438 -10,093 -2,522 -906 -684 79.64%
Tax Rate - - - - - - - -
Total Cost 27,938 19,378 11,415 11,069 2,656 1,016 920 76.53%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin -473.20 -1,861.34 -1,068.37 -1,034.12 -1,881.46 -822.64 -290.80 8.44%
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
EPS -0.45 -0.48 -0.29 -0.44 -0.20 -0.09 -0.07 36.32%
EPS Diluted -0.45 -0.48 -0.29 -0.44 -0.20 -0.09 -0.07 36.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.